Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis |
| |
| Authors: | Ji Sun Hwang Jung-Eun Kim Hee-Taek Kim Young-Beob Yu Sin-Hyeog Im |
| |
| Affiliation: | 1. School of Life Sciences and Immune Synapse Research Center, Gwangju Institute of Science and Technology (GIST), Gwangju 500–712, Republic of Korea;2. Department of Dermatology, College of Oriental Medicine, Semyung University, Jecheon 390–711, Republic of Korea;3. Department of Herbal Pharmaceutical Development, Nambu University, 864-1 Wolgye-dong, Gwangsan-gu, Gwangju 506–706, Republic of Korea |
| |
| Abstract: | |
| |
| Keywords: | TSE, Taglisodog-eum LPS, Lipopolysaccharide PMA, Phorbol 12-myristate 13-acetate AD, Atopic dermatitis Th1 & Th2, T helper 1 and T helper 2 IL-4, Interleukin 4 IL-5, Interleukin 5 IL-10, Interleukin 10 IL-13, Interleukin 13 IL-17, Interleukin 17 IL-31, Interleukin 31 IFN-γ, Interferon gamma TNF-α, Tumor necrosis factor alpha Foxp3, Forkhead box P3 HPRT, Hypoxanthine-guanine phosphoribosyltransferase DNCB, 2, 4-dinitrocholorobenzene PBS, Phosphate buffer saline NFκB, nuclear factor kappa-light-chain-enhancer of activated B cells Aicda, Activation-induced cytidine deaminase. |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
